Effect of intravenous infusion of OKY-1581 (sodium-(E)-3-[4-(3-pyridylmethyl)phenyl] -2-methylacrylate) on circulatory thromboxane A2 and prostacyclin levels in anaesthetized baboon.
作者信息
Roy A C, Adaikan P G, Karim S M
出版信息
Prostaglandins Med. 1981 Sep;7(3):253-9. doi: 10.1016/0161-4630(81)90104-x.
PMID:7029585
Abstract
摘要
相似文献
1
Effect of intravenous infusion of OKY-1581 (sodium-(E)-3-[4-(3-pyridylmethyl)phenyl] -2-methylacrylate) on circulatory thromboxane A2 and prostacyclin levels in anaesthetized baboon.
Prostaglandins Med. 1981 Sep;7(3):253-9. doi: 10.1016/0161-4630(81)90104-x.
2
Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Circulation. 1984 Oct;70(4):599-605. doi: 10.1161/01.cir.70.4.599.
3
Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.
Br Med J (Clin Res Ed). 1981 Nov 21;283(6303):1351-2. doi: 10.1136/bmj.283.6303.1351.
4
Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
Adv Prostaglandin Thromboxane Leukot Res. 1983;11:371-6.
5
Prostacyclin and thromboxane in diabetic children.
Prostaglandins Leukot Med. 1983 Jul;11(3):339-44. doi: 10.1016/0262-1746(83)90045-8.
6
Maternal prostacyclin, thromboxane, and placental blood flow.
Am J Obstet Gynecol. 1983 Mar 15;145(6):730-2. doi: 10.1016/0002-9378(83)90581-1.
7
Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT.
Eur J Radiol. 1985 Aug;5(3):243-5.
8
[Biochemistry of coronary artery disease--prostaglandins].
Rinsho Byori. 1983 Aug;31(8):854-9.
9
Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
Prostaglandins Leukot Med. 1983 Sep;12(1):49-52. doi: 10.1016/0262-1746(83)90066-5.
10
The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Stroke. 1985 Mar-Apr;16(2):241-4. doi: 10.1161/01.str.16.2.241.
Zotero 插件